Status:
UNKNOWN
17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor
Lead Sponsor:
Meir Medical Center
Conditions:
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Preterm deliveries play a significant role in neonatal morbidity and mortality. Previous studies showed that administration of progesterone to pregnant women at high risk, decrease spontaneous preterm...
Eligibility Criteria
Inclusion
- The subject has a history of spontaneous preterm delivery defined as earlier than 37 gestational week.
- The subject has a short cervical length defined as 25 mm before 24 weeks gestation.
- A singleton gestation.
Exclusion
- Multifetal pregnancy.
- The subject has or will have a cervical cerclage in place.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00809939
Start Date
December 1 2010
End Date
December 1 2012
Last Update
August 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel